UniProt ID | KKCC2_HUMAN | |
---|---|---|
UniProt AC | Q96RR4 | |
Protein Name | Calcium/calmodulin-dependent protein kinase kinase 2 | |
Gene Name | CAMKK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 588 | |
Subcellular Localization | Nucleus. Cytoplasm . Cell projection . Predominantly nuclear in unstimulated cells (By similarity). Found in the cytoplasm and neurites after forskolin induction.. | |
Protein Description | Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade involved in a number of cellular processes. Isoform 1, isoform 2 and isoform 3 phosphorylate CAMK1 and CAMK4. Isoform 3 phosphorylates CAMK1D. Isoform 4, isoform 5 and isoform 6 lacking part of the calmodulin-binding domain are inactive. Efficiently phosphorylates 5'-AMP-activated protein kinase (AMPK) trimer, including that consisting of PRKAA1, PRKAB1 and PRKAG1. This phosphorylation is stimulated in response to Ca(2+) signals (By similarity). Seems to be involved in hippocampal activation of CREB1 (By similarity). May play a role in neurite growth. Isoform 3 may promote neurite elongation, while isoform 1 may promoter neurite branching.. | |
Protein Sequence | MSSCVSSQPSSNRAAPQDELGGRGSSSSESQKPCEALRGLSSLSIHLGMESFIVVTECEPGCAVDLGLARDRPLEADGQEVPLDTSGSQARPHLSGRKLSLQERSQGGLAAGGSLDMNGRCICPSLPYSPVSSPQSSPRLPRRPTVESHHVSITGMQDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRHGAEPLPSEDENCTLVEVTEEEVENSVKHIPSLATVILVKTMIRKRSFGNPFEGSRREERSLSAPGNLLTKKPTRECESLSELKEARQRRQPPGHRPAPRGGGGSALVRGSPCVESCWAPAPGSPARMHPLRPEEAMEPE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSSCVSSQP ------CCCCCCCCC | 32.23 | 22814378 | |
32 | Ubiquitination | SSSSESQKPCEALRG CCCCCCHHHHHHHHH | 62.00 | - | |
32 (in isoform 7) | Ubiquitination | - | 62.00 | - | |
56 | O-linked_Glycosylation | MESFIVVTECEPGCA CCEEEEEEECCCCCE | 24.83 | 23301498 | |
85 | Phosphorylation | GQEVPLDTSGSQARP CCCCCCCCCCCCCCC | 42.54 | 29214152 | |
86 | Phosphorylation | QEVPLDTSGSQARPH CCCCCCCCCCCCCCC | 35.79 | 28555341 | |
88 | Phosphorylation | VPLDTSGSQARPHLS CCCCCCCCCCCCCCC | 22.04 | 29214152 | |
95 | Phosphorylation | SQARPHLSGRKLSLQ CCCCCCCCCCCCCCH | 33.25 | 29214152 | |
98 | Ubiquitination | RPHLSGRKLSLQERS CCCCCCCCCCCHHHH | 46.05 | - | |
98 (in isoform 7) | Ubiquitination | - | 46.05 | - | |
100 | Phosphorylation | HLSGRKLSLQERSQG CCCCCCCCCHHHHCC | 30.92 | 23401153 | |
114 | Phosphorylation | GGLAAGGSLDMNGRC CCCCCCCCCCCCCCE | 21.93 | 23186163 | |
125 | Phosphorylation | NGRCICPSLPYSPVS CCCEECCCCCCCCCC | 37.25 | 23927012 | |
128 | Phosphorylation | CICPSLPYSPVSSPQ EECCCCCCCCCCCCC | 30.79 | 23927012 | |
129 | Phosphorylation | ICPSLPYSPVSSPQS ECCCCCCCCCCCCCC | 19.52 | 30278072 | |
132 | Phosphorylation | SLPYSPVSSPQSSPR CCCCCCCCCCCCCCC | 39.42 | 30278072 | |
133 | Phosphorylation | LPYSPVSSPQSSPRL CCCCCCCCCCCCCCC | 27.48 | 30278072 | |
136 | Phosphorylation | SPVSSPQSSPRLPRR CCCCCCCCCCCCCCC | 45.77 | 25159151 | |
137 | Phosphorylation | PVSSPQSSPRLPRRP CCCCCCCCCCCCCCC | 14.59 | 23927012 | |
145 | Phosphorylation | PRLPRRPTVESHHVS CCCCCCCCCCCCCEE | 34.78 | 27282143 | |
148 | Phosphorylation | PRRPTVESHHVSITG CCCCCCCCCCEEEEC | 17.98 | 27251275 | |
152 | Phosphorylation | TVESHHVSITGMQDC CCCCCCEEEECHHHH | 15.29 | 28348404 | |
154 | Phosphorylation | ESHHVSITGMQDCVQ CCCCEEEECHHHHHH | 21.06 | 28348404 | |
173 | Ubiquitination | TLKDEIGKGSYGVVK EECCCCCCCCCEEEE | 50.79 | 21906983 | |
173 (in isoform 1) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 2) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 3) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 4) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 5) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 6) | Ubiquitination | - | 50.79 | 21906983 | |
173 (in isoform 7) | Ubiquitination | - | 50.79 | 21906983 | |
183 | Phosphorylation | YGVVKLAYNENDNTY CEEEEEEEECCCCCE | 33.18 | - | |
189 | Phosphorylation | AYNENDNTYYAMKVL EEECCCCCEEEEHHH | 22.29 | 27642862 | |
190 | Phosphorylation | YNENDNTYYAMKVLS EECCCCCEEEEHHHC | 8.76 | 17360941 | |
191 | Phosphorylation | NENDNTYYAMKVLSK ECCCCCEEEEHHHCH | 9.74 | 27642862 | |
194 | Ubiquitination | DNTYYAMKVLSKKKL CCCEEEEHHHCHHHH | 31.67 | - | |
194 (in isoform 7) | Ubiquitination | - | 31.67 | - | |
234 | Phosphorylation | RGPIEQVYQEIAILK CCHHHHHHHHHHHHH | 10.50 | 27642862 | |
241 | Ubiquitination | YQEIAILKKLDHPNV HHHHHHHHCCCCCCE | 45.22 | 21906983 | |
241 (in isoform 1) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 2) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 3) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 4) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 5) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 6) | Ubiquitination | - | 45.22 | 21906983 | |
241 (in isoform 7) | Ubiquitination | - | 45.22 | 21906983 | |
242 | Ubiquitination | QEIAILKKLDHPNVV HHHHHHHCCCCCCEE | 56.56 | - | |
242 (in isoform 7) | Ubiquitination | - | 56.56 | - | |
307 | Ubiquitination | IEYLHYQKIIHRDIK HHHHHHEEEECCCCC | 36.14 | - | |
307 (in isoform 7) | Ubiquitination | - | 36.14 | - | |
314 | Ubiquitination | KIIHRDIKPSNLLVG EEECCCCCHHHEEEC | 46.84 | 21906983 | |
314 (in isoform 1) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 2) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 3) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 4) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 5) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 6) | Ubiquitination | - | 46.84 | 21906983 | |
314 (in isoform 7) | Ubiquitination | - | 46.84 | 21906983 | |
327 | Ubiquitination | VGEDGHIKIADFGVS ECCCCCEEEEEECCC | 26.60 | - | |
338 | Ubiquitination | FGVSNEFKGSDALLS ECCCCCCCCCCHHHC | 51.86 | - | |
350 | Phosphorylation | LLSNTVGTPAFMAPE HHCCCCCCCCCCCCC | 13.70 | - | |
401 (in isoform 7) | Ubiquitination | - | 43.32 | - | |
403 | Ubiquitination | MCLHSKIKSQALEFP HHHHHHHHHHHHCCC | 40.01 | 2190698 | |
403 (in isoform 1) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 2) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 3) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 4) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 5) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 6) | Ubiquitination | - | 40.01 | 21906983 | |
403 (in isoform 7) | Ubiquitination | - | 40.01 | 21906983 | |
420 | Ubiquitination | PDIAEDLKDLITRML CCHHHHHHHHHHHHH | 63.91 | - | |
429 | Ubiquitination | LITRMLDKNPESRIV HHHHHHCCCCHHCCE | 71.13 | - | |
429 (in isoform 7) | Ubiquitination | - | 71.13 | - | |
441 | Ubiquitination | RIVVPEIKLHPWVTR CCEECCEECCCCCCC | 38.80 | - | |
441 (in isoform 4) | Ubiquitination | - | 38.80 | - | |
441 (in isoform 5) | Ubiquitination | - | 38.80 | - | |
441 (in isoform 7) | Ubiquitination | - | 38.80 | - | |
445 (in isoform 5) | Ubiquitination | - | 8.05 | - | |
452 (in isoform 4) | Phosphorylation | - | 52.54 | 25849741 | |
452 (in isoform 5) | Phosphorylation | - | 52.54 | 25849741 | |
452 (in isoform 6) | Phosphorylation | - | 52.54 | 25849741 | |
468 (in isoform 5) | Phosphorylation | - | 58.29 | 25849741 | |
476 (in isoform 5) | Ubiquitination | - | 35.32 | - | |
479 (in isoform 5) | Phosphorylation | - | 24.02 | 28355574 | |
479 (in isoform 6) | Phosphorylation | - | 24.02 | 22210691 | |
486 (in isoform 5) | Phosphorylation | - | 2.55 | 30257219 | |
486 (in isoform 6) | Phosphorylation | - | 2.55 | 22210691 | |
488 | Ubiquitination | LATVILVKTMIRKRS HHHHHHHHHHHHHHC | 29.00 | - | |
495 | Phosphorylation | KTMIRKRSFGNPFEG HHHHHHHCCCCCCCC | 40.31 | 19664994 | |
503 | Phosphorylation | FGNPFEGSRREERSL CCCCCCCCCCHHHCC | 22.44 | 23403867 | |
509 | Phosphorylation | GSRREERSLSAPGNL CCCCHHHCCCCCCCC | 29.92 | 25159151 | |
511 | Phosphorylation | RREERSLSAPGNLLT CCHHHCCCCCCCCCC | 33.39 | 23401153 | |
511 (in isoform 3) | Phosphorylation | - | 33.39 | 25849741 | |
518 | Phosphorylation | SAPGNLLTKKPTREC CCCCCCCCCCCCHHC | 39.94 | 23403867 | |
519 (in isoform 3) | Ubiquitination | - | 57.64 | - | |
522 | Phosphorylation | NLLTKKPTRECESLS CCCCCCCCHHCCCHH | 48.24 | 19369195 | |
522 (in isoform 2) | Phosphorylation | - | 48.24 | 22210691 | |
522 (in isoform 3) | Phosphorylation | - | 48.24 | 28355574 | |
529 (in isoform 2) | Phosphorylation | - | 50.60 | 22210691 | |
529 (in isoform 3) | Phosphorylation | - | 50.60 | 30257219 | |
559 | Phosphorylation | GSALVRGSPCVESCW CCCCCCCCCCCCCCE | 12.45 | 23532336 | |
572 | Phosphorylation | CWAPAPGSPARMHPL CEECCCCCCCCCCCC | 17.83 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
85 | T | Phosphorylation | Kinase | CAMKK2 | Q96RR4 | PSP |
511 | S | Phosphorylation | Kinase | DAPK1 | P53355 | PSP |
511 | S | Phosphorylation | Kinase | DAPK-FAMILY | - | GPS |
511 | S | Phosphorylation | Kinase | DAPK_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXL12 | Q9NXK8 | PMID:23707388 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KKCC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KKCC2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
OBSL1_HUMAN | OBSL1 | physical | 20562859 | |
FLNC_HUMAN | FLNC | physical | 20562859 | |
AAPK2_HUMAN | PRKAA2 | physical | 20562859 | |
GCN1_HUMAN | GCN1L1 | physical | 20562859 | |
XPOT_HUMAN | XPOT | physical | 20562859 | |
IQGA2_HUMAN | IQGAP2 | physical | 20562859 | |
PRKDC_HUMAN | PRKDC | physical | 20562859 | |
AAKG1_HUMAN | PRKAG1 | physical | 20562859 | |
FLNA_HUMAN | FLNA | physical | 20562859 | |
ATG4B_HUMAN | ATG4B | physical | 20562859 | |
ESYT2_HUMAN | ESYT2 | physical | 20562859 | |
MK14_HUMAN | MAPK14 | physical | 20562859 | |
FANCI_HUMAN | FANCI | physical | 20562859 | |
SMC1A_HUMAN | SMC1A | physical | 20562859 | |
SMC3_HUMAN | SMC3 | physical | 20562859 | |
M2OM_HUMAN | SLC25A11 | physical | 20562859 | |
IRAK1_HUMAN | IRAK1 | physical | 20562859 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495 AND SER-511,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-522 (ISOFORM 3),PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-479 (ISOFORM 5), ANDMASS SPECTROMETRY. |